Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America
- DOI
- 10.1016/j.jaip.2022.02.047
- Published
- 2022-09
- Container
- The Journal of Allergy and Clinical Immunology: In Practice
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.jaip.2022.02.047,
title = {Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America},
author = {Jennifer K. Quint and Sofie Arnetorp and Janwillem W.H. Kocks and Maciej Kupczyk and Javier Nuevo and Vicente Plaza and Claudia Cabrera and Chantal Raherison-Semjen and Brandie Walker and Erika Penz and Ileen Gilbert and Njira Lucia Lugogo and Ralf J.P. van der Valk and Andrew Fong and Christina Qian and Caroline Fabry-Vendrand and Chantal Touboul and Dorota Brzostek and Ekaterina Maslova and Filip Surmont and Helena Goike and Hitesh Gandhi and J.C. Korevaar and Joseph Tkacz and Karissa Johnston and Keith Peres da Costa and L. van Dijk and M. Vervloet and Michael Pollack and Paul Hernandez and Silvia Boarino and Stephen G. Noorduyn and Wendy Beekman-Hendricks and Y.M. Weesie},
year = {2022},
journal = {The Journal of Allergy and Clinical Immunology: In Practice},
doi = {10.1016/j.jaip.2022.02.047},
url = {https://doi.org/10.1016/j.jaip.2022.02.047}
}RIS
TY - JOUR TI - Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America AU - Jennifer K. Quint AU - Sofie Arnetorp AU - Janwillem W.H. Kocks AU - Maciej Kupczyk AU - Javier Nuevo AU - Vicente Plaza AU - Claudia Cabrera AU - Chantal Raherison-Semjen AU - Brandie Walker AU - Erika Penz AU - Ileen Gilbert AU - Njira Lucia Lugogo AU - Ralf J.P. van der Valk AU - Andrew Fong AU - Christina Qian AU - Caroline Fabry-Vendrand AU - Chantal Touboul AU - Dorota Brzostek AU - Ekaterina Maslova AU - Filip Surmont AU - Helena Goike AU - Hitesh Gandhi AU - J.C. Korevaar AU - Joseph Tkacz AU - Karissa Johnston AU - Keith Peres da Costa AU - L. van Dijk AU - M. Vervloet AU - Michael Pollack AU - Paul Hernandez AU - Silvia Boarino AU - Stephen G. Noorduyn AU - Wendy Beekman-Hendricks AU - Y.M. Weesie PY - 2022 JO - The Journal of Allergy and Clinical Immunology: In Practice DO - 10.1016/j.jaip.2022.02.047 UR - https://doi.org/10.1016/j.jaip.2022.02.047 ER -
APA
Quint, J. K., Arnetorp, S., Kocks, J. W., Kupczyk, M., Nuevo, J., Plaza, V., Cabrera, C., Raherison-Semjen, C., Walker, B., Penz, E., Gilbert, I., Lugogo, N. L., Valk, R. J. V. D., Fong, A., Qian, C., Fabry-Vendrand, C., Touboul, C., Brzostek, D., Maslova, E., Surmont, F., Goike, H., Gandhi, H., Korevaar, J., Tkacz, J., Johnston, K., Costa, K. P. D., Dijk, L. V., Vervloet, M., Pollack, M., Hernandez, P., Boarino, S., Noorduyn, S. G., Beekman-Hendricks, W., & Weesie, Y. (2022). Short-Acting Beta-2-Agonist Exposure and Severe Asthma Exacerbations: SABINA Findings From Europe and North America. The Journal of Allergy and Clinical Immunology: In Practice. https://doi.org/10.1016/j.jaip.2022.02.047
Source records
- crossref · retrieved 2026-09-25T11:04:24.781Z